Divi's Laboratories Limited
Divi's Laboratories Limited (DIVISLAB.NS) Stock Overview
Explore Divi's Laboratories Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.7T
P/E Ratio
68.43
EPS (TTM)
$93.11
ROE
0.17%
DIVISLAB.NS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Divi's Laboratories Limited (DIVISLAB.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 58.11, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6385.94.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 68.43 and a market capitalization of 1.7T. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.